Skip to main content
. 2022 Jan 14;30(3):349–362. doi: 10.1038/s41431-021-00987-7

Table 2.

External validation of PRS models in European populations using data from UK Biobank and CIMBA.

Model (data set) SNPs UK Biobank CIMBA BRCA1 carriersa CIMBA BRCA2 carriersa
AUC OR 95% CI AUC HR 95% CI AUC HR 95% CI
(a) PRS models based on OCAC data
Lasso (OCAC) 1403 0.587 1.37 1.27–1.48 0.573 1.27 1.21–1.34 0.627 1.48 1.33–1.63
Elastic net (OCAC) 10,797 0.588 1.36 1.26–1.47 0.583 1.32 1.26–1.39 0.617 1.47 1.33–1.63
Stepwise (OCAC) 22 0.588 1.35 1.26–1.46 0.563 1.21 1.16–1.26 0.605 1.39 1.26–1.54
Select and shrink (OCAC) 27,240 0.588 1.38 1.28–1.48 0.592 1.36 1.29–1.43 0.624 1.49 1.35–1.64
(b) PRS models based on meta-analysis of OCAC and CIMBA data
Stepwise (OCAC-CIMBA)b 36 0.595 1.39 1.29–1.50 NA NA NA NA NA NA
Select and shrink (OCAC-CIMBA) 18,007 0.596 1.42 1.32–1.54 NA NA NA NA NA NA

AUC area under the receiver operating characteristic curve, OR odds ratio, HR hazards ratio.

aEstimates are from unadjusted models.

bResults in CIMBA are overfitted as the CIMBA data was used for model development.